Etiology, 3-Month Functional Outcome and Recurrent Events in Non-Traumatic Intracerebral Hemorrhage
- PMID: 35677981
- PMCID: PMC9194537
- DOI: 10.5853/jos.2021.01823
Etiology, 3-Month Functional Outcome and Recurrent Events in Non-Traumatic Intracerebral Hemorrhage
Abstract
Background and purpose: Knowledge about different etiologies of non-traumatic intracerebral hemorrhage (ICH) and their outcomes is scarce.
Methods: We assessed prevalence of pre-specified ICH etiologies and their association with outcomes in consecutive ICH patients enrolled in the prospective Swiss Stroke Registry (2014 to 2019).
Results: We included 2,650 patients (mean±standard deviation age 72±14 years, 46.5% female, median National Institutes of Health Stroke Scale 8 [interquartile range, 3 to 15]). Etiology was as follows: hypertension, 1,238 (46.7%); unknown, 566 (21.4%); antithrombotic therapy, 227 (8.6%); cerebral amyloid angiopathy (CAA), 217 (8.2%); macrovascular cause, 128 (4.8%); other determined etiology, 274 patients (10.3%). At 3 months, 880 patients (33.2%) were functionally independent and 664 had died (25.1%). ICH due to hypertension had a higher odds of functional independence (adjusted odds ratio [aOR], 1.33; 95% confidence interval [CI], 1.00 to 1.77; P=0.05) and lower mortality (aOR, 0.64; 95% CI, 0.47 to 0.86; P=0.003). ICH due to antithrombotic therapy had higher mortality (aOR, 1.62; 95% CI, 1.01 to 2.61; P=0.045). Within 3 months, 4.2% of patients had cerebrovascular events. The rate of ischemic stroke was higher than that of recurrent ICH in all etiologies but CAA and unknown etiology. CAA had high odds of recurrent ICH (aOR, 3.38; 95% CI, 1.48 to 7.69; P=0.004) while the odds was lower in ICH due to hypertension (aOR, 0.42; 95% CI, 0.19 to 0.93; P=0.031).
Conclusions: Although hypertension is the leading etiology of ICH, other etiologies are frequent. One-third of ICH patients are functionally independent at 3 months. Except for patients with presumed CAA, the risk of ischemic stroke within 3 months of ICH was higher than the risk of recurrent hemorrhage.
Keywords: Cerebral hemorrhage; Etiology; Ischemic stroke; Outcome.
Figures





Similar articles
-
Primary Intracerebral Hemorrhage: A Closer Look at Hypertension and Cerebral Amyloid Angiopathy.Neurocrit Care. 2018 Aug;29(1):77-83. doi: 10.1007/s12028-018-0514-z. Neurocrit Care. 2018. PMID: 29556933
-
High Mortality Rates Among Patients With Non-Traumatic Intracerebral Hemorrhage and Atrial Fibrillation on Antithrombotic Therapy Are Independent of the Presence of Cerebral Amyloid Angiopathy: Insights From a Population-Based Study.J Am Heart Assoc. 2020 Aug 4;9(15):e016893. doi: 10.1161/JAHA.120.016893. Epub 2020 Jul 25. J Am Heart Assoc. 2020. PMID: 32715895 Free PMC article.
-
Etiologic and Clinical Characterization of Patients with Recurrent Spontaneous Intracerebral Hemorrhage.Eur Neurol. 2016;76(5-6):295-301. doi: 10.1159/000452659. Epub 2016 Nov 3. Eur Neurol. 2016. PMID: 27806359
-
Risk of intracranial haemorrhage and ischaemic stroke after convexity subarachnoid haemorrhage in cerebral amyloid angiopathy: international individual patient data pooled analysis.J Neurol. 2022 Mar;269(3):1427-1438. doi: 10.1007/s00415-021-10706-3. Epub 2021 Jul 17. J Neurol. 2022. PMID: 34272978 Free PMC article.
-
Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta-analysis.Int J Stroke. 2019 Oct;14(7):723-733. doi: 10.1177/1747493019830065. Epub 2019 Feb 20. Int J Stroke. 2019. PMID: 30785378
Cited by
-
Perfusion gradients promote delayed perihaematomal oedema in intracerebral haemorrhage.Brain Commun. 2023 Apr 24;5(3):fcad133. doi: 10.1093/braincomms/fcad133. eCollection 2023. Brain Commun. 2023. PMID: 37151226 Free PMC article.
-
Intracerebral haemorrhage - mechanisms, diagnosis and prospects for treatment and prevention.Nat Rev Neurol. 2024 Dec;20(12):708-723. doi: 10.1038/s41582-024-01035-w. Epub 2024 Nov 15. Nat Rev Neurol. 2024. PMID: 39548285 Review.
-
Association of the Presence and Pattern of MRI Markers of Cerebral Small Vessel Disease With Recurrent Intracerebral Hemorrhage.Neurology. 2023 Aug 22;101(8):e794-e804. doi: 10.1212/WNL.0000000000207510. Epub 2023 Jun 22. Neurology. 2023. PMID: 37349111 Free PMC article.
-
CADMUS: A Novel MRI-Based Classification of Spontaneous Intracerebral Hemorrhage Associated With Cerebral Small Vessel Disease.Neurology. 2024 Jan 9;102(1):e207977. doi: 10.1212/WNL.0000000000207977. Epub 2023 Dec 15. Neurology. 2024. PMID: 38165372 Free PMC article.
-
Prothrombin Complex Concentrate vs Conservative Management in ICH Associated With Direct Oral Anticoagulants.JAMA Netw Open. 2024 Feb 5;7(2):e2354916. doi: 10.1001/jamanetworkopen.2023.54916. JAMA Netw Open. 2024. PMID: 38319661 Free PMC article.
References
-
- Cordonnier C, Demchuk A, Ziai W, Anderson CS. Intracerebral haemorrhage: current approaches to acute management. Lancet. 2018;392:1257–1268. - PubMed
-
- Hostettler IC, Seiffge DJ, Werring DJ. Intracerebral hemorrhage: an update on diagnosis and treatment. Expert Rev Neurother. 2019;19:679–694. - PubMed
-
- Shoamanesh A, Patrice Lindsay M, Castellucci LA, Cayley A, Crowther M, de Wit K, et al. Canadian stroke best practice recommendations: management of spontaneous intracerebral hemorrhage, 7th edition update 2020. Int J Stroke. 2021;16:321–341. - PubMed
-
- Steiner T, Al-Shahi Salman R, Beer R, Christensen H, Cordonnier C, Csiba L, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke. 2014;9:840–855. - PubMed
-
- Adams HP, Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35–41. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources